Allurion Technologies Quote - ALUR

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.3499

Bid

Offer

Volume

744,341

0.2801 Day's Range 0.356408

0.26 52 Week Range 4.00

Market Cap

22.564M

Previous Close

0.2799

Open

0.3151

Last Trade

300

0.3499

(formt)

Last Trade Time

Financial Volume

US$ 240,321

VWAP

0.322864

Average Volume (3m)

414,273

Shares Outstanding

64,486,517

Dividend Yield

PE Ratio

-0.27

Earnings Per Share (EPS)

-1.28

Revenue

53.47M

Net Profit

-82.3M

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient ... Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. Show more

Sector

Blank Checks

Industry

Blank Checks

Headquarters

Wilmington, Delaware, USA

Founded

Allurion Technologies Inc is listed in the Blank Checks sector of the New York Stock Exchange with ticker ALUR. The last closing price for Allurion Technologies was US$0.28. Over the last year, Allurion Technologies shares have traded in a share price range of US$ 0.26 to US$ 4.00.

Allurion Technologies currently has 64,486,517 shares in issue. The market capitalisation of Allurion Technologies is US$18.05 million. Allurion Technologies has a price to earnings ratio (PE ratio) of -0.27.

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock...

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

AllurionMeds is designed to address a critical demand from patients: The Weight Must Stay Off Features Coach Iris, a first-of-its-kind conversational AI behavioral agent for weight loss and...

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced its financial results for the third quarter ended September 30, 2024...

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

19,428 patients treated with the Allurion Program across 72 countries lost an average of 12.2% of total body weight Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending...

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the third quarter 2024 on...

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the submission of the first three modules of its premarket approval application (PMA) to the U.S...

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

In a study of 167 patients, average weight reduction was 15.7% at four months, 17.1% at six months, and 14.7% at one year Body fat percentage decreased at six months with no change in muscle...

Coverage Initiation And Bullish Price Target Sends Micro Cap Flying

A healthcare company based out of Massachusetts is getting a lot of attention this morning after it was announced that TD Cowen initiated coverage on the stock with a Buy rating To read the full...

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Systematic review of 11 studies involving 2,107 patients reports average weight reduction of 12.5% with significant improvements in metabolic health Allurion Technologies, Inc. (NYSE: ALUR), a...

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it received written notice (the “Notice”) from the New York...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0014	0.401721664275	0.3485	0.35995	0.26	428052	0.32180787	CS
4	-0.1777	-33.6808188021	0.5276	0.534999	0.26	801133	0.36652722	CS
12	-0.2744	-43.9532276149	0.6243	0.8	0.26	414273	0.44031503	CS
26	-0.8501	-70.8416666667	1.2	3.55	0.26	875774	1.81734396	CS
52	-2.9801	-89.4924924925	3.33	4	0.26	710742	2.25565203	CS
156	-8.6501	-96.1122222222	9	9	0.26	538588	2.3843771	CS
260	-8.6501	-96.1122222222	9	9	0.26	538588	2.3843771	CS

ALUR - Frequently Asked Questions (FAQ)

What is the current Allurion Technologies share price?

The current share price of Allurion Technologies is US$ 0.3499

How many Allurion Technologies shares are in issue?

Allurion Technologies has 64,486,517 shares in issue

What is the market cap of Allurion Technologies?

The market capitalisation of Allurion Technologies is USD 18.05M

What is the 1 year trading range for Allurion Technologies share price?

Allurion Technologies has traded in the range of US$ 0.26 to US$ 4.00 during the past year

What is the PE ratio of Allurion Technologies?

The price to earnings ratio of Allurion Technologies is -0.27

What is the cash to sales ratio of Allurion Technologies?

The cash to sales ratio of Allurion Technologies is 0.41

What is the reporting currency for Allurion Technologies?

Allurion Technologies reports financial results in USD

What is the latest annual turnover for Allurion Technologies?

The latest annual turnover of Allurion Technologies is USD 53.47M

What is the latest annual profit for Allurion Technologies?

The latest annual profit of Allurion Technologies is USD -82.3M

What is the registered address of Allurion Technologies?

The registered address for Allurion Technologies is 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

Which industry sector does Allurion Technologies operate in?

Allurion Technologies operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VNCEVince Holding Corp	US$ 4.70 (69.06%)	1.06M
SRFMSurf Air Mobility Inc	US$ 3.33 (23.79%)	376.77k
BBBlackBerry Limited	US$ 3.685 (23.66%)	40.8M
ALURAllurion Technologies Inc	US$ 0.3439 (22.87%)	744.34k
CLWClearWater Paper Corporation	US$ 30.26 (22.46%)	3.5M
IIPRInnovative Industrial Properties Inc	US$ 73.50 (-22.91%)	3.15M
KUKEKuke Music Holding Limited	US$ 0.31 (-20.51%)	61.48k
NVONovo Nordisk	US$ 85.00 (-17.83%)	53.81M
CANGCango Inc	US$ 5.08 (-11.81%)	2.44M
BNEDBarnes and Noble Education Inc	US$ 9.965 (-10.31%)	1.55M
QBTSD Wave Quantum Inc	US$ 6.638 (4.21%)	124.42M
PFEPfizer Inc	US$ 26.36 (2.29%)	116.33M
APOApollo Global Management Inc	US$ 171.03 (0.83%)	94.52M
TAT&T Inc	US$ 22.75 (0.80%)	93.94M
FFord Motor Company	US$ 9.885 (1.49%)	87.66M

oleskool 1 month ago

really . and this trades SMH

👍️0

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Allurion Technologies Inc (ALUR) Share Price

Allurion Technologies Inc (ALUR)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Allurion Technologies Inc

Ask ADVFN Intelligence (AI)

ALUR Latest News

ALUR - Frequently Asked Questions (FAQ)

Movers

ALUR Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free